Co-Diagnostics CEO Dwight Egan said: “We, the long term of reference PCR diagnostics will be explained through the convenience of home and point-of-service testing, which will be critical to achieving standardization. Our new platform, lately in progression and subject to regulatory approval, will allow Americans and organizations to know temporarily and as their COVID-19 status should be, with self-testing that can also be done in multiple contexts. 19 vaccines, which would possibly take years to fully administer globally.
“2020 was a pivotal year for Co-Diagnostics as we built a global network of providers that will provide a forged foundation for our continued success. Now that we move up to our line of diagnostic verification products for infectious diseases that kill millions of people Every one year, before starting our vertical liquid biopsy and proceeding to supply our must-have COVID-19 products, Co-Diagnostics hopes to be in a long-term position with the next generation of PCR devices and reference controls for the home and the point. -of sanitary environments “.